Mobile

You are not alone!

Tomorrow’s NTRK Fusion-Positive Cancer Treatment Today

Get ahead of standard treatments for NTRK fusion-positive cancer. Participating in a clinical trial for NTRK fusion-positive cancer gives you access to the latest therapies.

Call +1 844 627 7246

    Find treatment options now

    A Patient Advocate will reach out to you in less than 24 hours.

    Your personal data is fully confidential and 100% secure

      Find treatment options now

      A Patient Advocate will reach out to you in less than 24 hours.

      Your personal data is fully confidential and 100% secure

      Understanding Your Options for Treating NTRK Fusion-Positive Cancer

      If your doctor has told you that your cancer is NTRK fusion positive, it means that an important gene has joined together, or fused, with another. The NTRK gene produces a protein that’s needed for healthy development and survival of nerve cells. (There are actually three versions of the gene, known as NTRK1, NTRK2, and NTRK3.) Like certain other genes, NTRK can, in rare cases, fuse with other genes. An NTRK gene fusion has been found to promote the spread of several forms of solid-tumor cancer. NTRK mutations, or DNA errors, may also occur in this gene, though less is known about this alteration.  

      Several drugs that target the NTRK gene fusion and slow the spread of cancer have become available in recent years. For patients who test positive for this genetic abnormality, clinical trials of NTRK inhibitors are another option.  

       

      What Are Clinical Trials? 

      A clinical trial is a research study in which scientists evaluate the effectiveness and safety of new medical treatments. That includes new drugs or novel combinations of drugs for treating cancer and other diseases. Every drug approved by the U.S. Food and Drug Administration had to be tested first in clinical trials.  

      Why Massive Bio?
      Our AI matching tool makes cancer treatment simple.

      We combine the power of technology with our dedicated team of medical providers to find you the best treatment options available.

      Access the free matching tool

      How Massive Bio Helps Patients With NTRK Fusion-Positive Cancer

      Massive Bio offers a quick, easy, and FREE way to find clinical trials for patients like you. With our unique clinical trial matching system and compassionate team, Massive Bio can rapidly match you to clinical trials of new therapies. If you aren’t sure if your cancer is NTRK fusion positive, that’s okay. Additional testing can help determine your exact diagnosis. 

      Hear from our Co founder & CEO

      Selin Kurnaz on how she struggled to find the right treatment for her uncle and started Massive Bio to help others.

      There is a major gap between what pharmaceutical companies are working on right now vs. what cancer patients are getting. Massive Bio is revolutionizing this process.
      Selin Kurnaz, Co-Founder, CEO
      People's stories
      Star Star Star Star Star

      “Massive Bio has gone above and beyond to connect my family with the right care during Covid-19. I really appreciate their staff’s consistent and clear outreach during this process.“

      Mylan Tran
      Cancer Patient Caregiver
      Google Reviews
      You are in good hands

      Talk to us. Our nurses and patient advocates are here and happy to help you. You are not alone in this fight.

      Call +1 844 627 7246
      Cancer Clinical Trials Patients Cancer Clinical Trials Patients

      What is a HER2-Positive Cancer clinical trial?

      Clinical trials test the latest scientific advancements in HER2-Positive cancer treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. HER2-Positive cancer patients can gain access to promising drugs and innovative treatments long before they're made available to the public.

      Cancer Ribbon
      About Massive Bio

      At Massive Bio, our goal is to ensure that all cancer patients have access to clinical trials of innovative new treatments that offer hope for improved outcomes. Our unique SYNERGY-AI technology rapidly generates a personalized clinical trial matching report, which is FREE to patients and doctors.